Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
Arijit Dasgupta, Debabrata MukherjeeGill Heart Institute, University of Kentucky, Lexington, KY, USAAbstract: It is estimated that approximately a quarter of patients undergoing coronary intervention may have significant post-procedural creatinine (CK)/creatinine kinase myocardial band (CK-MB) eleva...
Main Authors: | Arijit Dasgupta, Debabrata Mukherjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-03-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/use-of-clopidogrel-in-the-reduction-of-myocardial-damage-during-percut-a2983 |
Similar Items
-
Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
by: Guangtao Yao, et al.
Published: (2017-12-01) -
Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01) -
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Nicholas B Norgard, et al.
Published: (2009-10-01) -
Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
by: Wei Zheng, et al.
Published: (2019-01-01) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)